Plus   Neg

Imperial Brands CEO Alison Cooper To Resign

UK-based tobacco giant Imperial Brands plc (IMB.L,IMBBF.PK,IMBBY.PK) announced Thursday that its Chief Executive Officer Alison Cooper will step down from the role of CEO and from the Board once a suitable successor is found.

Till then, Cooper will focus on driving the performance of the business, including the asset divestment programme, which is expected to realise proceeds of up to 2 billion pounds by May 2020.

Cooper has been with Imperial for the past 20 years, nine of which have been as CEO.

Chairman Mark Williamson, said, "During her tenure as CEO the business has been significantly simplified and reshaped to strengthen its long-term growth potential, and more than £10 billion in dividends has been returned to shareholders."

Imperial Brands recently had issued a disappointing outlook for fiscal 2019 due to the challenging Next Generation Products or NGP market in the USA and changes to the company's results expectations in the Africa, Asia and Australasia division.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
Follow RTT